• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-04-23

  This study dissects how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids in mice. By integrating transporter and enzyme expression analyses, the paper highlights mechanisms underlying pharmacokinetic variability and provides guidance for optimizing preclinical MASH therapies.

• ω-Agatoxin IVA TFA: Precision for Translational Neuroprotect

  2026-04-22

  This thought-leadership article explores the mechanistic and translational impact of ω-Agatoxin IVA TFA, a nanomolar-precision P/Q-type calcium channel blocker. It synthesizes recent mechanistic insights, validated epilepsy model data, and actionable guidance for translational researchers, while contrasting APExBIO’s product with conventional tools. The article contextualizes ω-Agatoxin IVA TFA’s role in synaptic transmission research and neuroprotective strategies, referencing both key peer-reviewed findings and best practice workflows.

• Connexin 43/NF-κB Axis in AngII-Induced Macrophage Polarizat

  2026-04-22

  This study demonstrates that Angiotensin II drives RAW264.7 macrophage polarization toward the pro-inflammatory M1 phenotype via upregulation of connexin 43 and activation of the NF-κB (p65) pathway. Inhibition of connexin 43 or NF-κB signaling suppresses M1 marker expression, highlighting a mechanistic link with potential implications for cardiovascular and inflammatory disease research.

• Otilonium Bromide: Translational Leverage in Cholinergic Res

  2026-04-21

  This article empowers translational researchers with mechanistic insights and strategic guidance for deploying Otilonium Bromide as a high-purity antimuscarinic agent in advanced neuroscience and smooth muscle research. By bridging molecular pharmacology with evolving clinical models, we map out new opportunities for cholinergic pathway modulation and highlight best practices for robust, reproducible experimental design.

• Deep Learning-Based Cardiotoxicity Detection in iPSC-CMs

  2026-04-21

  This study presents a scalable platform using deep learning and high-content imaging to rapidly identify cardiotoxic compounds in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). By integrating phenotypic screening with advanced computational methods, the research addresses key barriers in early-stage drug safety assessment and highlights translational tools to streamline cardiac electrophysiology research.

• Rotigotine as a Dopaminergic Modulator: Mechanistic Insights

  2026-04-20

  Explore how Rotigotine, a potent dopamine D2/D3 receptor agonist, advances neuropsychiatric research by bridging Parkinson’s disease and depression models. This article delivers a mechanistic deep-dive and practical assay recommendations, setting it apart from standard protocol guides.

• Vernakalant Hydrochloride: Precision Workflows for Rapid AF

  2026-04-20

  Vernakalant Hydrochloride (RSD1235) delivers atrial-selective antiarrhythmic action, enabling rapid conversion of atrial fibrillation with minimal ventricular risk. This article distills advanced experimental workflows, troubleshooting insights, and comparative guidance for leveraging Vernakalant Hydrochloride in both in vitro and in vivo AF research.

• Pharmacokinetic Variability of CSBTA in MASH: New Insights f

  2026-04-19

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. By mapping the interplay between pathological status, metabolic enzymes, and transporters, the research offers valuable guidance for optimizing therapeutic regimens in MASH and related metabolic liver diseases.

• TPPU in sEH Inhibition: Precision, Protocols, and the Nrf2 A

  2026-04-18

  Explore the unique role of TPPU as a potent soluble epoxide hydrolase inhibitor, with a focus on its mechanistic impact on the Nrf2 pathway and bone-immune crosstalk. This article delivers practical assay guidance and protocol insights distinct from existing resources.

• Dissecting Drug Response in Cancer: Fractional vs. Relative

  2026-04-17

  Schwartz's dissertation advances in vitro cancer drug evaluation by rigorously distinguishing proliferative arrest from cell death using dual metrics—fractional and relative viability. This nuanced approach clarifies drug mechanisms and supports more reproducible apoptosis induction assays, directly informing systems pharmacology and translational research.

• Kir2.1 Inhibition Suppresses PASMC Proliferation and Migrati

  2026-04-16

  This study demonstrates that inhibition of the Kir2.1 potassium channel reduces pulmonary artery smooth muscle cell (PASMC) proliferation and migration, key drivers of pulmonary vascular remodeling in pulmonary hypertension. The research illuminates Kir2.1's regulatory role via the TGF-β1/SMAD2/3 pathway, offering mechanistic insights relevant for targeted cardiovascular modeling.

• Ginsenoside Rg1 Restores Gut-Brain-Immune Balance After Anes

  2026-04-15

  A recent study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neurobehavioral and neuroimmune deficits induced by prolonged isoflurane anesthesia in mice. The findings highlight a Treg-dependent mechanism linking gut barrier integrity, systemic inflammation, and hippocampal function, offering new insight for neuroprotection research.

• Propranolol: Applied Use in Cardiovascular and Memory Resear

  2026-04-14

  Propranolol, a non-selective β-adrenergic receptor blocker, enables precise modulation of cardiovascular and neurobehavioral pathways in translational research. This article details hands-on workflows, protocol refinements, and troubleshooting strategies, leveraging APExBIO’s high-purity Propranolol for reproducible results in both in vitro and in vivo models.

• Lamotrigine in CNS Research: Workflow Optimization & BBB Mod

  2026-04-13

  Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) is a gold standard for sodium channel and serotonin pathway interrogation in cutting-edge CNS and cardiac research. Discover how high-purity Lamotrigine from APExBIO enables robust blood-brain barrier workflows, advanced epilepsy-induced arrhythmia modeling, and troubleshooting strategies for translational assay success.

• Indomethacin for Inflammation and Lipid Metabolism Research

  2026-04-13

  Indomethacin, a potent nonsteroidal anti-inflammatory drug, is redefining experimental strategies in inflammation and lipid metabolism research. Here, we dissect advanced workflows and troubleshooting insights, spotlighting its role in adipocyte differentiation studies and membrane signaling modulation.

11379 records 1/759 page Next 12345 下5页 Last page